Product Image

Advanced Sleep Melatonin 10 mg Time Release

Natrol
4.6
★ ★ ★ ★ ★
(84483 ratings)
Melatonin 10 mg
Product Image
Score78
A practical time-release tablet for sleep onset and maintenance, limited by a fixed 10 mg dose. It best fits users who already know that amount works for them.
How scoring works
Quantity:100 Tablet(s) • (100 servings)
Goals:
Sleep Support

Score 78

A practical time-release tablet for sleep onset and maintenance, limited by a fixed 10 mg dose. It best fits users who already know that amount works for them.
How scoring works
$11.95($0.11 per serving)
Walmart
$ 20.40
iHerb
$ 17.32
Vitacost
$ 16.13
Amazon
$ 11.95
iHerb
$ 17.32
Report prices

Analysis

The time-release tablet pairs direct circadian support with delivery intended to continue overnight. One tablet provides the full 10 mg amount, making the directions simple.

A 10 mg serving exceeds the lower amounts many people use successfully and may increase vivid dreams or morning grogginess. The added vitamin B6 and calcium do not meaningfully broaden the sleep formula.

The large supply and low serving cost suit ongoing use for someone who already tolerates the amount. Users seeking flexible or conservative dosing would be better served by a lower-strength option.

Who is it for
  • Adults who want time-release melatonin
  • People who tolerate a 10 mg serving
  • Users seeking a long-lasting supply
Best for
  • Overnight delivery
  • Sleep timing
  • One-tablet convenience

Pros

  • Time-release format may support staying asleep
  • Clear one-tablet serving
  • Large number of servings
  • Low ongoing cost

Cons

  • 10 mg is a high amount
  • Dose cannot be adjusted easily
  • Added nutrients provide limited sleep-specific benefit

Warnings

  • The 10 mg time-release serving may leave residual morning drowsiness
  • Vivid dreams or headache may occur at this amount
  • Avoid alertness-dependent activities if effects persist after waking

Nutrient quality

72 High impact

Time-release delivery supports overnight maintenance. The high melatonin amount and low-value additions weaken balance.

.

Ingredient transparency

85 Highest impact

Active amounts and the time-release serving are clearly disclosed. Complete directions and inactive ingredients remain absent.

.

Customer satisfaction

71 High impact

Customer sentiment is favorable. An exceptionally large rating base makes the average highly dependable, while no narrative feedback was supplied.

.

Value for money

85 Highest impact

Serving economics are highly favorable. Formula quality supports fair practical value.

.
Report analysis

Goals

Sleep Support
Impact
High effect
A+ Goal FitC+ Strength of SupportC CoverageB+ Formula Quality
Melatonin · 10 mg

Melatonin is directly relevant to sleep timing and difficulty falling asleep. The time-release tablet provides a clearly stated 10 mg serving.

The amount is far above physiological-dose options and may increase vivid dreams or next-day grogginess. The time-release design may extend support overnight, though the high amount can still cause morning grogginess.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Vitamin B6 (Pyridoxine Hydrochloride)
10 mg
Calcium (Dibasic Calcium Phosphate)
23 mg
Melatonin
10 mg
Adults 18–50 Dairy Free Vegetarian
Report overview
Melatonin · 10 mg OverallScore57
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyA- Value

The time-release tablet is designed to support sleep maintenance and provides the complete serving in one unit. Its high melatonin amount may raise the risk of next-day grogginess despite the controlled-release benefit. Cost is near the collection median, while independent purity verification is not disclosed.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  3. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis.
    Li T; Jiang S; Han M; Yang Z; Lv J; Deng C; Reiter RJ; Yang Y · Frontiers in neuroendocrinology · 2019
    Meta-analysis205 participants7 studies pooledSleep Support forMelatonin
  4. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  5. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  6. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  7. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin